Who Owns Amneal Pharmaceuticals Stock?
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 48.98%
- Institutions (% of float)
- 102.72%
- Held by insiders
- 52.32%
- Institutional holders
- 466
- Institutions 47.7%
- Insiders 52.3%
- Public and other 0.0%
Who owns Amneal Pharmaceuticals stock?
Institutional investors own about 49.0% of Amneal Pharmaceuticals's shares, spread across 466 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 52.32% of AMRX.
The largest institutional holders are Blackrock Inc. (8.77%), Vanguard Portfolio Management LLC (4.03%) and TPG GP A, LLC (4.02%). Together, the top 10 institutions control 31.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their AMRX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AMRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 26.88M | 8.77% | +1.2% |
| Vanguard Portfolio Management LLC | 12.37M | 4.03% | +1.9% |
| TPG GP A, LLC | 12.33M | 4.02% | 0.0% |
| Rubric Capital Management LP | 10.17M | 3.32% | -7.9% |
| Vanguard Capital Management LLC | 7.99M | 2.61% | +3.6% |
| State Street Corporation | 7.47M | 2.44% | +1.6% |
| Invesco Ltd. | 5.97M | 1.95% | +70.3% |
| Dimensional Fund Advisors LP | 5.82M | 1.90% | +0.4% |
| Geode Capital Management, LLC | 4.57M | 1.49% | -11.1% |
| Morgan Stanley | 4.27M | 1.39% | +3.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AMRX
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 10.99M | 3.59% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.56M | 1.81% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 4.03M | 1.31% |
| iShares Trust-iShares Russell 2000 ETF | 4.02M | 1.31% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 2.55M | 0.83% |
| Invesco Exchange-Traded Fund Trust-Invesco S&P SmallCap Momentum ETF | 2.08M | 0.68% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.97M | 0.64% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.87M | 0.61% |
| SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF | 1.68M | 0.55% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 1.24M | 0.40% |
Frequently asked questions
Who is the largest shareholder of Amneal Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of AMRX, owning 8.77% of shares outstanding (26.88M shares) as of its latest 13F filing.
What percentage of Amneal Pharmaceuticals is owned by institutions?
Institutions own about 49.0% of AMRX shares and 102.7% of the public float.
How much of Amneal Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 52.32% of AMRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.